AG Mayes sued pharmaceutical manufacturer GlaxoSmithKline (GSK) for engaging in deceptive and unfair practices that endangered vulnerable asthma patients, especially children, while exploiting taxpayers. The lawsuit alleges that GSK deliberately discontinued its widely used asthma medication, Flovent, and replaced it with an identical authorized generic as part of a calculated scheme to avoid paying Medicaid rebates tied to years of price inflation. 

"GSK put corporate greed ahead of the health and safety of Arizona’s families and children. Their manipulation of the system has left countless patients without access to life-saving medication, caused a spike in emergency room visits, and likely contributed to preventable deaths. My office will not stand by while corporations put profit ahead of the health of children." – AG Mayes